Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation

Takikawa O, 1986, J Biol Chem, 261, 3648, 10.1016/S0021-9258(17)35696-X

10.1016/j.ejmech.2016.05.061

10.1093/oxfordjournals.jbchem.a131115

10.1007/s00262-008-0513-6

10.1371/journal.pone.0014698

10.1038/nri1457

10.1038/nm934

10.1016/j.molmed.2003.11.003

10.4049/jimmunol.177.8.5639

10.1007/s00262-010-0891-4

10.1021/acs.jmedchem.7b00974

10.1158/0008-5472.CAN-06-2925

10.1021/jm900518f

10.2174/156800909790192374

10.1158/1078-0432.CCR-11-1331

10.1186/2051-1426-2-3

10.1038/nm1196

10.1016/j.ejmech.2018.08.013

10.1038/nbt0415-321

Available from: <http://clinicaltrials.gov/show/NCT01191216> [last accessed 27 Feb 2017].

Available from: <http://clinicaltrials.gov/show/NCT00567931> [last accessed 27 Feb 2017].

10.1016/0003-9861(91)90142-6

Available from: https://integrity.thomsonpharma.com/integrity/xmlxsl/pk_qcksrch.show_records?sessionID=1&history=&query=GDC0919&abbreviation=PRO&language=en.

10.1158/1538-7445.AM2013-491

10.1021/acsmedchemlett.6b00391

Tumang J, Gomes B, Wythes M, et al. PF-06840003: a highly selective IDO-1 inhibitor that shows good in vivo efficacy in combination with immune checkpoint inhibitors. 107th Annu Meet Am Assoc Cancer Res (AACR); 2016 April 16–20; New Orleans.

Balog A. Discovery of a selective inhibitor of indoleamine-2,3-dioxygenase for use in the therapy of cancer. 253rd Am Chem Soc (ACS) Natl Meet; 2017 April 2–6; San Francisco.

10.1002/1873-3468.12784

10.1039/C5RA25046C

10.1021/ci400429g

10.1016/j.ddtec.2013.02.002

10.1021/ci400382r

., 2013, Molecular Operating Environment (MOE)

10.1039/c3cp54723j

10.1021/ci400114f

10.1073/pnas.0508996103

10.1021/ml500247w

10.1021/acs.jmedchem.5b01390

GOLD, version 5.1

10.1006/jmbi.1996.0897

10.1002/jcc.10306

10.1002/jcc.20933

10.1002/jcc.21256

2015, Glide, version 6.6

10.1002/prot.20389

10.1016/j.bmc.2016.01.024

10.1007/s11095-008-9679-z

10.1016/j.ejmech.2014.03.061

10.1021/ci200237c

10.1021/jm0603365

10.1021/ci8004226

10.1021/jm901137j

2012, OMEGA, 2.4.6

10.1021/ci030285+

10.1016/j.ejmech.2014.06.078

10.1021/acs.jmedchem.5b00326

10.1002/hlca.19880710312

10.3233/JAD-2010-100684

10.1021/jm401195n